Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125207571 | 12520757 | 1 | I | 20160623 | 20160701 | 20160701 | EXP | US-ENDO PHARMACEUTICALS INC.-2016-004179 | ENDO | 0.00 | F | Y | 69.01000 | KG | 20160701 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125207571 | 12520757 | 1 | PS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Unknown | 8085 | UNKNOWN | ||||||||||
125207571 | 12520757 | 2 | C | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125207571 | 12520757 | 1 | Rheumatoid arthritis |
125207571 | 12520757 | 2 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125207571 | 12520757 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125207571 | 12520757 | Abdominal discomfort | |
125207571 | 12520757 | Breast cancer | |
125207571 | 12520757 | Diarrhoea | |
125207571 | 12520757 | Pneumonia | |
125207571 | 12520757 | Unevaluable event |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125207571 | 12520757 | 2 | 2010 | 0 |